Biotechnology indicators by execution sector.

• Select values to consult
  • Indicator type

    Values that contain

    Units carrying out R&D in Biotechnology % Units by type of biotechnology used: Genetic Code % Units by type of biotechnology used: Functional Units % Units by type of biotechnology used: Cell and Tissue Culture and Engineering % Units by type of biotechnology used: Bioprocesses % Units by type of biotechnology used: Subcellular Organisms % Units by type of biotechnology used: Bioinformatics % Units by type of biotechnology used: Nanobiotechnology % Units by type of biotechnology used: Other Units in which biotechnology activities are: Main and/or exclusive Units in which biotechnology activities are: A secondary business line Units in which biotechnology activities are: A necessary tool for production % Units by final application areas of biotechnology use: Human Health % Units by final application areas of biotechnology use: Animal Health and Aquaculture % Units by final application areas of biotechnology use: Food Products % Units by final application areas of biotechnology use: Agriculture and Forestry % Units by final application areas of biotechnology use: Environment % Units by final application areas of biotechnology use: Industry R&D personnel in Biotechnology (PP) R&D personnel in Biotechnology (PP): Research personnel R&D personnel in Biotechnology (PP): Technical and auxiliary personnel R&D personnel in Biotechnology (PP). Women R&D personnel in Biotechnology (PP). Women: Research personnel R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel R&D personnel in Biotechnology (FTE) R&D personnel in Biotechnology (FTE): Research personnel R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel R&D personnel in Biotechnology (FTE). Women R&D personnel in Biotechnology (FTE). Women: Research personnel R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel Expenditure on internal R&D in Biotechnology (thousands of euros) 1) By type of expenditure: Current expenditure 1.1) Labour expenditure of research personnel 1.2) Labour expenditure of technical and auxiliary personnel 1.3) Other current expenditure 2) By type of expenditure: Capital expenditure 2.1) Land and buildings 2.2) Equipment and tools 2.3) Acquisition of specific R&D software 2.4) Other R&D-specific IP products 1.1) By origin of funds: Own funds 1.2) By origin of funds: Funds from the Business sector 1.3) By origin of funds: Funds from the Public Administration sector 1.4) By origin of funds: Funds from the Higher Education sector 1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector 1.6) By origin of funds: Funds from the rest of the world Purchase of R&D services (external R&D) in Biotechnology (thousands of euros) Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world % Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital % Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information % Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources % Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain % Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets % Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels % Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception % Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements % Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost % Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting

    Selected:59

    Total:59
  • Execution Sectors

    Values that contain

    Total Companies Public Administration Higher Education NPPI

    Selected:1

    Total:5
• Choose format of the table

  • 	Execution Sectors
    Indicator type	.	.	.
    	.	.	.
    	.	.	.

  • Decimals to show: By default 0 1 2
• Notes
  • 1) Data referring to all companies and organisations that carry out internal R&D in Biotechnology.
    2) ' .'= numeric data equal to zero not resulting from rounding
    3) FTE: Full-Time Equivalence

• Source:National Statistics Institute